3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Myelodysplastic Syndromes
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Hematologic Neoplasms
9
Myeloproliferative Disorders
8
Multiple Myeloma
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Hodgkin Disease
7
Lymphoma, Non-Hodgkin
6
Graft vs Host Disease
6
Waldenstrom Macroglobulinemia
5
Lymphoma
5
Burkitt Lymphoma
5
Recurrence
4
Primary Myelofibrosis
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
4
Lymphoma, Mantle-Cell
4
Leukemia, Prolymphocytic
4
Leukemia, Myelomonocytic, Chronic
4
Skin Neoplasms
3
Sarcoma
3
Rhabdomyosarcoma
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Biphenotypic, Acute
3
Leukemia
3
Bronchiolitis Obliterans Syndrome
3
Interventions
Gemcitabine
56
pembrolizumab
50
Cisplatin
43
Magnetic Resonance Spectroscopy
27
enfortumab vedotin
22
Specimen Handling
22
Nivolumab
22
Cystectomy
18
durvalumab
16
Carboplatin
16
avelumab
15
Mitomycin
14
atezolizumab
13
Docetaxel
13
Cystoscopy
12
Fluorouracil
11
Radiation
9
Transurethral Resection of Bladder
8
Radiotherapy
8
Ipilimumab
8
sacituzumab govitecan
7
Standard of Care
7
Radiosurgery
7
Paclitaxel
7
Immunoglobulin G
7
Disulfides
7
erdafitinib
6
cemiplimab
6
Surveys and Questionnaires
6
Surgical Procedures, Operative
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
Sirolimus
×
1 year
×
Clear all
No trials found.